Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment
Open Access
- 5 February 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1259
Abstract
The purpose of this study is to evaluate the concentration of vascular endothelial growth factor (VEGF) in the vitreous humor of patients with primary rhegmatogenous retinal detachment (RRD). This is a prospective case control study. Eighteen patients with primary RRD without proliferative vitreoretinopathy C (PVR C) were enrolled as cases, and twenty-two non-diabetic retinopathy patients who were candidates for complete pars plana vitrectomy due to Macular Hole or Epiretinal Membrane were included as the control group. Undiluted vitreal samples were collected during the initiation of Pars Plana Vitrectomy (PPV) prior to any infusion into the posterior cavity. Vitreous samples were also collected from 21 fresh cadaveric globes. The vitreous concentration of VEGF was measured by enzyme-linked immunosorbent assay (ELISA) technique and compared between these two groups. The vitreal concentration of VEGF was 0.643 ± 0.088 ng/mL in the RRD group. Measured concentrations of VEGF in controls were 0.043 ± 0.104 ng/mL, and in cadaveric eyes they were 0.033 ± 0.058 ng/mL. The mean VEGF concentration in the RRD group was statistically higher than in the control group (p < 0.0001) and cadaveric eyes (p < 0.0001). Our study shows that vitreal VEGF concentrations significantly increase in patients with RRD.Keywords
This publication has 18 references indexed in Scilit:
- Ranibizumab Is a Potential Prophylaxis for Proliferative Vitreoretinopathy, a Nonangiogenic Blinding DiseaseThe American Journal of Pathology, 2013
- ANTIANGIOGENIC ISOFORMS OF VASCULAR ENDOTHELIAL GROWTH FACTOR PREDOMINATE IN SUBRETINAL FLUID OF PATIENTS WITH RHEGMATOGENOUS RETINAL DETACHMENT AND PROLIFERATIVE VITREORETINOPATHYRetina, 2012
- Vitreous Vascular Endothelial Growth Factor Concentrations in Proliferative Diabetic Retinopathy versus Proliferative VitreoretinopathyOphthalmic Research, 2011
- Vitreous Levels of VEGF, IL-8, and TNF-α in Retinal DetachmentCurrent Eye Research, 2010
- Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgeryAmerican Journal of Ophthalmology, 2004
- Detection of Vascular Endothelial Growth Factor and Tumor Necrosis Factor Alpha in Epiretinal Membranes of Proliferative Diabetic Retinopathy, Proliferative Vitreoretinopathy and Macular PuckerOphthalmologica, 1998
- Hypoxic Regulation of Vascular Endothelial Growth Factor in Retinal CellsArchives of Ophthalmology (1950), 1995
- RETINAL OXYGEN DISTRIBUTIONRetina, 1995
- Immunocytology of Cellular Components in Vitreous and Subretinal Fluid from Patients with Proliferative VitreoretinopathyOphthalmologica, 1991
- Changing Concepts of Failures After Retinal Detachment SurgeryArchives of Ophthalmology (1950), 1979